Questionnaire in Screening Older Patients With Cancer
This study has been completed.
Sponsor:
Institut Bergonié
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00963911
First received: August 21, 2009
Last updated: May 12, 2011
Last verified: May 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
RATIONALE: A screening questionnaire may help doctors plan better treatment for older patients with cancer.
PURPOSE: This clinical trial is studying a questionnaire in screening older patients with cancer.
| Condition | Intervention |
|---|---|
|
Breast Cancer Colorectal Cancer Head and Neck Cancer Lung Cancer Lymphoma Prostate Cancer |
Other: medical chart review Other: screening questionnaire administration Procedure: comparison of screening methods Procedure: quality-of-life assessment |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Masking: Open Label Primary Purpose: Screening |
| Official Title: | Validation of a Screening Tool in Geriatric Oncology |
Resource links provided by NLM:
Genetics Home Reference related topics:
breast cancer
MedlinePlus related topics:
Breast Cancer
Cancer
Colorectal Cancer
Head and Neck Cancer
Lung Cancer
Lymphoma
Prostate Cancer
U.S. FDA Resources
Further study details as provided by National Cancer Institute (NCI):
Primary Outcome Measures:
- Validation of G8 screening tool [ Designated as safety issue: No ]
| Estimated Enrollment: | 1650 |
| Study Start Date: | June 2008 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
OBJECTIVES:
Primary
- Validate a new screening tool (G8).
Secondary
- Validate the French version of the screening tool "Vulnerable Elders Survey (VES-13)".
- Evaluate the merits of the screening tools (G8 and VES-13).
- Assess the screening tool in specific populations.
- Assess the number and type of interventions proposed after thorough geriatric assessment.
- Compare the two new tools (G8 vs VES-13).
OUTLINE: This is a multicenter study.
During the first consultation, patients have an initial clinical evaluation questionnaire comprising the G8. They also complete the self-questionnaire VES-13. Within 30 days, patients have a thorough geriatric assessment, including quality of life and physical function, by a physician without access to the G8 or VES-13 questionnaires. A blood specimen is also collected.
Information on health status and quality of life is collected from medical records or from the doctor after 1 and 5 years.
Eligibility| Ages Eligible for Study: | 70 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
DISEASE CHARACTERISTICS:
Histologically confirmed cancer including the following types:
- Colon
- Rectal
- Lung
- Squamous cell carcinoma of the head and neck
- Breast
- Prostate
- Non-Hodgkin lymphoma
- Planning to undergo first-time treatment comprising medicine, surgery, or radiotherapy
PATIENT CHARACTERISTICS:
- No persons deprived of liberty or under guardianship
- No psychological, familial, social, or geographical reasons that would make monitoring clinically impossible
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Contacts and Locations More Information
Additional Information:
No publications provided
| ClinicalTrials.gov Identifier: | NCT00963911 History of Changes |
| Other Study ID Numbers: | CDR0000637122, IB-ONCODAGE, IB 2008-06, RECF0891 |
| Study First Received: | August 21, 2009 |
| Last Updated: | May 12, 2011 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Cancer Institute (NCI):
|
colon cancer rectal cancer non-small cell lung cancer small cell lung cancer hypopharyngeal squamous cell carcinoma laryngeal squamous cell carcinoma laryngeal verrucous carcinoma lip and oral cavity squamous cell carcinoma |
oral cavity verrucous carcinoma nasopharyngeal squamous cell carcinoma oropharyngeal squamous cell carcinoma paranasal sinus and nasal cavity squamous cell carcinoma salivary gland squamous cell carcinoma prostate cancer breast cancer adult non-Hodgkin lymphoma |
Additional relevant MeSH terms:
|
Breast Neoplasms Colorectal Neoplasms Head and Neck Neoplasms Lung Neoplasms Lymphoma Prostatic Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Digestive System Diseases Gastrointestinal Diseases |
Colonic Diseases Intestinal Diseases Rectal Diseases Respiratory Tract Neoplasms Thoracic Neoplasms Lung Diseases Respiratory Tract Diseases Neoplasms by Histologic Type Lymphoproliferative Disorders Lymphatic Diseases Immunoproliferative Disorders Immune System Diseases Genital Neoplasms, Male Urogenital Neoplasms Genital Diseases, Male |
ClinicalTrials.gov processed this record on May 19, 2013